Evidence map›Paper›PMID 27257442›Full record

ArticleClinical epigenetics2016

Erratum to: The integrative epigenomic-transcriptomic landscape of ER positive breast cancer.

Yang Gao, Allison Jones, Peter A Fasching, Matthias Ruebner, Matthias W Beckmann, Martin Widschwendter, Andrew E Teschendorff

Abstract readPublished Erratum
In one paragraph

Article in Clinical epigenetics, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

7 authors.

Yang GaoCAS Key Lab for Computational Biology, CAS-MPG Partner Institute for Computational Biology, Chinese Academy of Sciences, Shanghai Institute for Biological Sciences, 320 Yue Yang Road, Shanghai, 200031 China.
Allison JonesDepartment of Women's Cancer, University College London, 74 Huntley Street, London, WC1E 6BT UK.
Peter A FaschingDepartment of Gynaecology and Obstetrics, Friedrich-Alexander University Erlangen-Nuremberg, University Clinic Erlangen, Erlangen, 91054 Germany.
Matthias RuebnerDepartment of Gynaecology and Obstetrics, Friedrich-Alexander University Erlangen-Nuremberg, University Clinic Erlangen, Erlangen, 91054 Germany.
Matthias W BeckmannDepartment of Gynaecology and Obstetrics, Friedrich-Alexander University Erlangen-Nuremberg, University Clinic Erlangen, Erlangen, 91054 Germany.
Martin WidschwendterDepartment of Women's Cancer, University College London, 74 Huntley Street, London, WC1E 6BT UK.
Andrew E TeschendorffCAS Key Lab for Computational Biology, CAS-MPG Partner Institute for Computational Biology, Chinese Academy of Sciences, Shanghai Institute for Biological Sciences, 320 Yue Yang Road, Shanghai, 200031 China ; Department of Women's Cancer, University College London, 74 Huntley Street, London, WC1E 6BT UK ; Statistical Genomics Group, Paul O'Gorman Building, UCL Cancer Institute, University College London, 72 Huntley Street, London, WC1E 6BT UK.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

PMID27257442
PMCPMC4890493

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.